EWTX
NASDAQ · Pharmaceuticals
Edgewise Therapeutics Inc
$45.32
-1.62 (-3.45%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+200.13%
YTD
+90.82%
Open$46.79
Previous Close$46.94
Day High$46.93
Day Low$45.32
52W High$48.51
52W Low$13.85
Volume—
Avg Volume1.42M
Market Cap5.00B
P/E Ratio—
EPS$-1.85
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$26.49
Above
SMA 200
$18.41
Above
RSI (14)
53.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+55.4% upside
Current
$45.32
$45.32
Target
$70.44
$70.44
$45.77
$70.44 avg
$86.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 407.17M | 429.50M | 324.39M |
| Net Income | 72.15M | 91.13M | 54.38M |
| Profit Margin | 17.7% | 21.2% | 16.8% |
| EBITDA | 147.48M | 172.82M | 113.17M |
| Free Cash Flow | 69.60M | 65.40M | 42.96M |
| Rev Growth | +16.1% | +0.2% | +22.1% |
| Debt/Equity | 0.29 | 0.25 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |